Related Experiment Video
Updated: Jul 7, 2026
Retzius-Sparing Robot-Assisted Radical Prostatectomy
Published on: May 19, 2022
Salvage radiotherapy for patients with PSA relapse after radical prostatectomy: a single institution experience
Laurent Quero1, Pierre Mongiat-Artus, Vincent Ravery
1Department of Radiation Oncology, Saint Louis Hospital, 1 avenue Claude Vellefaux, 75010 Paris, France. laurent.quero@wanadoo.fr
Background:
To assess the efficacy of salvage radiotherapy (RT) for persistent or rising PSA after radical prostatectomy and to determine prognostic factors identifying patients who may benefit from salvage RT.
Methods:
Between 1990 and 2003, 59 patients underwent RT for PSA recurrence after radical prostatectomy. Patients received a median of 66 Gy to the prostate bed with 3D or 2D RT. The main end point was biochemical failure after salvage RT, defined as an increase of the serum PSA value >0.2 ng/ml confirmed by a second elevation.
Results:
Median follow-up was 38 months. The 3-year and 5-year bDFS rates were 56.1% and 41.2% respectively. According to multivariate analysis, only preRT PSA > or =1 ng/ml was associated with biochemical relapse.
Conclusion:
When delivered early, RT is an effective treatment after radical prostatectomy. Only preRT PSA > or =1 ng/ml predicted relapse.
